 Business Update
May 23, 2024
Shoe Carnival Reports First Quarter Fiscal 2024 Results: An Encouraging Upswing Evansville, Ind. Shoe Carnival, Inc. (Nasdaq: SCVL), a notable name in the world of family footwear and accessories, revealed a promising start to its fiscal year as it announced results for the first quarter ended May 4, 2024. The com...
|
Business Update
May 23, 2024
By CSIMarket.com March 2023 - In a strategic move aimed at accelerating its infrastructure goals and strengthening its financial position, Frontier Communications Parent, Inc. (NASDAQ: FYBR) has executed a crucial amendment to its revolving credit facility. This amendment, while highly technical in nature, carries ...
|
Product Service News
May 23, 2024
In a groundbreaking development, Theriva Biologics, a leading clinical-stage company focused on cancer therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its lead clinical candidate VCN-01. VCN-01, when used in combination with gemcitabine and nab-pac...
|
|
 Product Service News
May 23, 2024
WOBURN, Mass., May 23, 2024 - Colonial Electric Supply, a renowned independent and family-owned electrical distributor, has recently made a strategic decision to optimize its eCommerce website s product discovery capabilities. The company has chosen Bridgeline Digital s HawkSearch, powered by the innovative Optimize...
 Clinical Study
May 23, 2024
Inozyme Pharma, a clinical-stage biopharmaceutical company focused on rare diseases, recently announced the presentation of top-line data from its ongoing Phase 1/2 trials of INZ-701. The trials aim to evaluate the safety and efficacy of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency, including those a...
|
|
Our most Popular Articles
|
Clinical Study
July 2, 2024
Combining the articles:HOOKIPA Pharma Inc. made an electrifying announcement today, revealing that the first person has been dosed in a Phase 1b clinical trial for HB-500. This groundbreaking investigational therapeutic vaccine aims to revolutionize the treatment of HIV, offering hope for millions of affected indivi...
|
Business Update
September 5, 2024
In the bustling corridors of innovation, where steel meets ethereal possibilities, there lies a luminous junction between terrestrial transit and the boundless expanse of the digital realm. Such a convergence is presently witnessed in the remarkable partnership between the esteemed Central Japan Railway Company, kno...
|
Financing Agreement
May 13, 2024
MiNK Therapeutics Secures $5.8 Million in Private Placement and Adds Board Observer for Accelerated Clinical Trials of MiNK-215
NEW YORK, May 13, 2024 - MiNK Therapeutics, Inc. (NASDAQ: INKT), a trailblazing clinical-stage biopharmaceutical company focused on the development, discovery, and commercialization of ...
|
|
|
Company News
|
Business Update
May 23, 2024
By CSIMarket.com March 2023 - In a strategic move aimed at accelerating its infrastructure goals and strengthening its financial position, Frontier Communications Parent, Inc. (NASDAQ: FYBR) has executed a crucial amendment to its revolving credit facility. This amendment, while highly technical in nature, carries ...
|
Product Service News
May 23, 2024
In a groundbreaking development, Theriva Biologics, a leading clinical-stage company focused on cancer therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its lead clinical candidate VCN-01. VCN-01, when used in combination with gemcitabine and nab-pac...
|
Announcement
May 23, 2024
Results of the Millicom (Tigo) AGM and EGM held today, along with the Convening Notice for the Annual General Meeting and Extraordinary General Meeting of Shareholders, showcase the company s commitment to transparency and growth. Additionally, Millicom (Tigo) has announced its proposed offering of Senior Notes due ...
|
|
|
Company News
 Announcement
May 23, 2024
|
Company News
 Product Service News
May 23, 2024
|
Company News
 Product Service News
May 23, 2024
|
More Company News
|
Product Service News
May 23, 2024
|
Announcement
May 23, 2024
|
Contract
May 23, 2024
|
Business Update
May 23, 2024
|
Product Service News
May 23, 2024
|
Announcement
May 23, 2024
|
Clinical Study
May 23, 2024
|
Management Changes
May 23, 2024
|
Financing Agreement
May 23, 2024
|
Management Announcement
May 23, 2024
|
|
|
|
Related News
|
Product Service News
|
Management Announcement
|
|
Stocks
|
Business Update
|
Announcement
|
Business Update
|
|
|
|
Business News
|
 Product Service News
WOBURN, Mass., May 23, 2024 - Colonial Electric Supply, a renowned independent and family-owned electrical distributor, has recently made a strategic decision to optimize its eCommerce website s product discovery capabilities. The company has chosen Bridgeline Digital s HawkSearch, powered by the innovative Optimize...
|
|
Clinical Study
Inozyme Pharma, a clinical-stage biopharmaceutical company focused on rare diseases, recently announced the presentation of top-line data from its ongoing Phase 1/2 trials of INZ-701. The trials aim to evaluate the safety and efficacy of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency, including those a...
|
 Business Update
By CSIMarket.com Westlake Corporation (NYSE: WLK), a diversified industrial company known for its strong market positions in building products and chemicals, has announced several strategic initiatives aimed at bolstering its presence in various markets and driving innovation. These initiatives include a new PVCO ...
|
 Business Update
In a recent announcement, Tango Therapeutics, a clinical-stage biotechnology company focused on advancing precision cancer medicines, revealed the discontinuation of its TNG348 program. The decision came as a result of emerging data from a dose escalation study, which showed significant liver toxicity among patients...
|
 Business Update
Shoe Carnival Reports First Quarter Fiscal 2024 Results: An Encouraging Upswing Evansville, Ind. Shoe Carnival, Inc. (Nasdaq: SCVL), a notable name in the world of family footwear and accessories, revealed a promising start to its fiscal year as it announced results for the first quarter ended May 4, 2024. The com...
|
Our Most Popular Articles
|
 Clinical Study
Combining the articles:HOOKIPA Pharma Inc. made an electrifying announcement today, revealing that the first person has been dosed in a Phase 1b clinical trial for HB-500. This groundbreaking investigational therapeutic vaccine aims to revolutionize the treatment of HIV, offering hope for millions of affected indivi...
|
 Business Update
In the bustling corridors of innovation, where steel meets ethereal possibilities, there lies a luminous junction between terrestrial transit and the boundless expanse of the digital realm. Such a convergence is presently witnessed in the remarkable partnership between the esteemed Central Japan Railway Company, kno...
|
 Financing Agreement
MiNK Therapeutics Secures $5.8 Million in Private Placement and Adds Board Observer for Accelerated Clinical Trials of MiNK-215
NEW YORK, May 13, 2024 - MiNK Therapeutics, Inc. (NASDAQ: INKT), a trailblazing clinical-stage biopharmaceutical company focused on the development, discovery, and commercialization of ...
|
More News
|
 Business Update
By CSIMarket.com March 2023 - In a strategic move aimed at accelerating its infrastructure goals and strengthening its financial position, Frontier Communications Parent, Inc. (NASDAQ: FYBR) has executed a crucial amendment to its revolving credit facility. This amendment, while highly technical in nature, carries ...
|
 Product Service News
In a groundbreaking development, Theriva Biologics, a leading clinical-stage company focused on cancer therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its lead clinical candidate VCN-01. VCN-01, when used in combination with gemcitabine and nab-pac...
|
 Announcement
Results of the Millicom (Tigo) AGM and EGM held today, along with the Convening Notice for the Annual General Meeting and Extraordinary General Meeting of Shareholders, showcase the company s commitment to transparency and growth. Additionally, Millicom (Tigo) has announced its proposed offering of Senior Notes due ...
|
 Announcement
Genasys Inc., the global leader in Protective Communications, has recently announced its participation in The MicroCap Rodeo Spring into Summer Conference. Richard Danforth, CEO, and Brian Alger, SVP of IR and Corporate Development, are scheduled to present at the event held at Convene in New York City. This confere...
|
 Product Service News
TransUnion, a leading global information solutions provider, reported a significant increase in data breach severity during the first quarter of 2024. While unveiling their advanced personalized identity threat intelligence technology at the FinovateSpring conference, the company highlighted the alarming rise in dat...
|
 Product Service News
Intra-Cellular Therapies Unveils Groundbreaking Data at ASCP Annual MeetingIntra-Cellular Therapies, Inc. (ITCI), a leading biopharmaceutical company specializing in therapeutics for central nervous system (CNS) disorders, has recently showcased groundbreaking data at the American Society of Clinical Psychopharmacol...
|
 Product Service News
XWELL, a leading authority in wellness solutions for people on the go, is steadfast in its commitment to providing cost-effective wellness services that drive top-line growth. The company has recently introduced its latest innovation, Ceragem V6, a massage solution available at select XpresSpa locations in the Unit...
|
 Announcement
In a bold stride toward integrating cryptocurrency with everyday transactions, Bitcoin Depot has recently announced a strategic partnership with New England-based convenience retailer Nouria Energy. This collaboration will see the installation of 57 new Bitcoin ATM kiosks across various locations, starting from the ...
|
 Contract
NV5 Global, Inc. (Nasdaq: NVEE), a leading provider of technology, conformity assessment, and consulting solutions, has been awarded a significant $12 million in geospatial contracts targeting the defense, intelligence, and federal civilian sectors. The company, headquartered in Hollywood, Florida, announced these c...
|
|
Business Update
Extensive Guardant Health Temporarily Halted, FDA Panel Reviewing Blood Test for Colorectal Cancer ScreeningPalo Alto-based precision oncology company, Guardant Health Inc. (Nasdaq: GH), has recently made two important announcements. Firstly, the trading of the company s stock has been temporarily halted by Nasdaq....
|
 Product Service News
OneMedNet Reports Significant Expansion of iRWD Network and Platform for Real World DataMINNEAPOLIS, May 23, 2024 - OneMedNet Corporation (Nasdaq: ONMD), a leading curator of regulatory-grade Real World Data (RWD), has announced a remarkable expansion of its proprietary iRWD network and platform. This development ma...
|
 Announcement
Macerich Unveils Strategic Plan to Foster Growth and Financial Stability Macerich, a prominent real estate investment trust (REIT) specializing in the acquisition, leasing, and management of regional shopping centers, has announced a comprehensive strategic plan aimed at streamlining operations, enhancing performanc...
|
 Clinical Study
The field of biodefense has significantly evolved in recent years with the emergence of novel threats, necessitating the development of more efficient and rapid countermeasures. In line with this , TFF Pharmaceuticals and Leidos have joined forces under the DARPA PPB program to advance next-generation medical countermeasures (MCMs) using TFF Pharmaceuticals proprietary Thin Film Freezing Technology. This article provides an overview of how this collaboration will facilitate the preclinical testing and formulation of innovative biodefense countermeasures.Thin Film Freezing Technology: A Revolutionary ApproachThin Film Freezing (TFF) is a cutting-edge technology developed by TFF Pharmaceuticals that enables the conversion of complex large-molecule therapeutics into highly stable and ultra-pure powders. This technique involves the homogenous dispersion of therapeutic agents in a solution that is quickly frozen on a flat surface and removed as a frozen film. The resultant thin film is then lyophilized to obtain a dry powder formulation. This method eliminates the need for conventional freeze-drying, minimizing potential degradation and preserving the therapeutic integrity of the drug.
|
 Management Changes
1. Sandy Spring Bancorp Appoints New CFO Amid Decline in Return on Investment
In a recent press release, Sandy Spring Bancorp announced the appointment of Charles S. Cullum as the company s new Chief Financial Officer, effective immediately. In addition, Philip J. Mantua will support the leadership transition u...
|
 Financing Agreement
EagleBank Supports Public Charter Schools with Financing for School Renovation Project
EagleBank, a prominent community bank in the Washington, D.C. area, has recently provided financing to Mamie D. Lee LLC to support improvements for public charter schools. Mamie D. Lee LLC, jointly owned by Briya Public Charte...
|
 Management Announcement
Energy Monster s Smart Share Global Recovers Compliance with Nasdaq Minimum Bid Price Requirement
SHANGHAI, China, May 23, 2024 - In an official announcement, Smart Share Global Limited (Nasdaq: EM), commonly known as Energy Monster, revealed that it has successfully regained compliance with the Nasdaq minimum...
|
|
|
|
|
